
Orchestra BioMed Holdings Inc (OBIO)
NASDAQ
Fin d'année 31 Décembre 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -0.215 | -0.234 | -2.379 | -60.164 |
Return on Equity (%) | -6.96 | -71.645 | 50.243 | -160.791 |
Return on Invested Capital (%) | 10.087 | 10.486 | 55.949 | -178.425 |
Operating Margin (%) | N/A | N/A | N/A | -1779.71 |
Net Profit Margin (%) | N/A | N/A | N/A | -1779.71 |
Book Value Per Share | 29.483 | 35.069 | 2.708 | 1.267 |
Earnings Per Share | -0.033 | -0.085 | -0.122 | -0.914 |
Cash Per Share | 0.382 | 0.394 | 0.008 | 0.569 |
Working Capital Per Share | 0.383 | 0.367 | -0.064 | 1.45 |
Operating Profit Per Share | N/A | N/A | N/A | 0.048 |
EBIT Per Share | -0.033 | -0.085 | -0.122 | -0.914 |
EBITDA Per Share | -0.033 | -0.085 | -0.122 | -0.914 |
Free Cash Flow Per Share | -0.033 | -0.085 | -0.122 | -0.918 |
Fin d'année 31 Décembre 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A |
Actions en circulation | 5,31M | 4,45M | 4,45M | N/A |
Fin d'année 31 Décembre 2023 | Juin 2022 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||||
Actions en circulation | 4,45M | 4,45M | 4,45M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | -939.863 | N/A | -2171.452 | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | -939.863 | N/A | -2171.452 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 150,91M |
Ratio cours/bénéfice | -3,06 |
Ratio prix/ventes | 54,55 |
Ratio prix/liquidités | 4,93 |
Ratio prix/valeur comptable | 2,21 |
Rendement de dividende | - |
Actions en circulation | 38,01M |
Volume moyen (1 semaine) | 61,2k |
Volume moyen (1 mois) | 52,4k |
Variation sur 52 semaines | -33,33% |
Plus haut sur 52 semaines | 8,8699 |
Plus bas sur 52 semaines | 3,75 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales